Skip to main content
Clinical Trials/ACTRN12613001334796
ACTRN12613001334796Terminated未知

Cognitive Bias Modification (CBM) for the Prevention of Depression Among People with Subsyndromal Depressive Symptoms.

niversity of Western Australia0 sites510 target enrollmentStarted: December 5, 2013Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Terminated
Sponsor
Enrollment
510

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional
Allocation
Randomised controlled trial
Primary Purpose
Prevention
Masking
Blinded (masking used)

Eligibility Criteria

Ages
45 Years to o limit (—)
Sex
All

Inclusion Criteria

  • Patient Health Questionnaire (PHQ-9) total score between 5 and 14 (inclusive)
  • - Age 45 years or over
  • - Fluent in written and spoken English
  • - Easy daily access to a computer with internet connection

Exclusion Criteria

  • - Current major depressive episode according to DSM-V criteria
  • - Past diagnosis of schizophrenia, schizoaffective disorder or bipolar disorder
  • - Past clinical history of stroke or of neurodegenerative diseases (e.g., Parkinson's disease)
  • - Evidence of harmful or hazardous consumption of alcohol (Alcohol Unit Disorders Identification Test - AUDIT = 15)
  • - Evidence of cognitive impairment (Modified Telephone Interview for Cognitive Status, TICSm < 27)
  • - Severe visual impairment that compromises ability to read
  • - Severe medical illness that may compromise ongoing participation in the study for 12 months (e.g., metastatic cancer)
  • - No general practitioner
  • - No written informed consent

Investigators

Sponsor
niversity of Western Australia

Similar Trials

COgnitive bias modification to Prevent... | Clinical Trial